1. Synthesizing: Coming to an Investment Opinion smartwomansecurities November 28, 2007 MORGEN PECK FIDELITY These materials are made for educational purposes and should not be distributed. All materials are for SWS members’ use only

2. Announcements Competition Section due Today! Next sections (financials & valuation) due Wed Nov. 28 NO seminar Wed. Nov. 21 (Happy Thanksgiving!) SWS Investment Conference Friday Nov, 30 from 4-7pm at Faculty Club –Attendance is MANDATORY

3. In this seminar Synthesizing all the information from previous seminars –Taking all that we have learned and applying it in practice Stock pitches –How to actually pitch your stock

4. DCF (let’s try this again) $1 today is worth more than a $1 in the future because of inflation –I can buy a hamburger for $1 today –5 years from now, I might only be able to afford a stick of gum for $1. I definitely will not be able to buy a hamburger for $1. Because of inflation, the value of money decreases over time. Example from last week: –Expect a business to make $1000 at the end of each year and then fold after 3 years, estimating a discount rate of 10% DCF = $1000/(1.1)+$1000/(1.1 2 )+ $1000/(1.1 3 ) = $2,487 = $909 + $826 + $751 = $2487 You should only pay $2,487 for this business. So if there are 100 shares outstanding, a fair price for the stock would be $24.87

5. putting it all together

6. Recap of Last 3 Weeks Finding stock ideas –Finding stocks that seem interesting (based on trends, Lynch/Buffett’s principles, your own observations) –WSJ, Financial Times, Economist Qualitative Analysis –Going to their websites, reading reports, etc. –Think about what industry it belongs in, who are major competitors? –Think about if recent success/difficulties company is facing are likely to persist –Good framework is Porter’s Five Forces

7. Recap of Last 3 Weeks Cont’d Fundamental Analysis –Look at income statement, balance sheet, statement of cash flows –Revenue growth, EPS growth, profit margins, ROE, ROA Valuation Analysis –P/E, Discounted Cash Flow >> is all the good or bad news reflected in the stock price? Coming to an Investment Opinion

8. Research analysts How research analysts on Wall Street view financials –Create EPS estimates based on their assumptions about the company and its future performance –Create financial models –Produce research reports SWS research methods follow similar principles

9. stock pitches

10. Logistics Research Analysts and Associates present stock pitches at weekly Investment Board meetings Roughly 15-20 minutes for each stock pitch, including presentation time and Q&A

11. Stock pitch Every stock pitch needs to communicate 2 major points: #1: IS THIS A GOOD BUSINESS? #2: WILL THIS BE A GOOD STOCK?

12. Stock pitch IS THIS A GOOD BUSINESS? Company Overview –What does the company do? Brief company & mgmt history. –Characteristics of the business: Large player or tiny player? Is it a growth business or more stable (or declining)? Industry Analysis –Define the industry the company competes in –How fast is industry growing? –Competitive landscape. What is your company’s mkt share? –Porter’s Five Forces Note: sources for this info are in the 10K & Annual reports: MD&A, Company Description

13. Stock pitch cont’d IS THIS A GOOD BUSINESS? Financial Statement Analysis –Tie #s to your statements/observations –Revenue growth, EPS growth, profit margins (I/S) –ROE, ROA (B/S) –FCF generation (CF Statement) Economic Landscape –What external macroeconomic factors will affect the stock?

14. Stock pitch cont’d WILL THIS BE A GOOD STOCK? Opportunities and Risks –Future growth prospects & risks Technical Analysis/Valuation –Stock price history (if it blew up, figure out why) –Valuation tools: P/E & DCF P/E vs. growth rate of EPS P/E across different companies Investment recommendation –What type of investor should invest, time horizon, what the target price is expected to be, etc.

15. Making a recommendation One-year time horizon Target price (estimated EPS x P/E, or DCF) Buy, sell, or hold recommendation

16. stock pitch: MON

17. Company Overview MON is $53B market cap manufacturer of seeds with genetic traits (corn, soy, cotton, vegetable) Their seeds increase yields (how much is grown per acre) which increases farmer income. Large cap growth stock Founded in 1901. Went public in 2000 as a subsidiary of Pharmacia. Spun off of 2002 as an independent company.

18. Industry Overview MON competes in the global corn, soybean, cotton and vegetable genetic seed market. MON has on average ~50% mkt share Genetic seeds are taking share from conventional seeds because they produce more. Major competitors are Syngenta, DuPont and Dow >> core competency are chemicals, not genetic seeds

19. Troubled Times for MON When MON was spun off in 2000, 36% of revenues was from Roundup (patented chemical sprayed on crops to kill weeds). Roundup came off patent in 2002, at which point generic competition entered the market (low barriers to entry), and thus pricing & MON’s profitability (Operating Income, EPS) declined.

20. > 1/3 MON revs from Roundup

21. Roundup Pricing Declining MON losing market share

22. MON EPS & P/E declined…

23. …MON stock price crushed

24. New CEO Hugh Grant Hugh Grant joined MON in 2000, became CEO on 5/03 Hugh saw what no one else was looking at…

25. Huge R&D Seed Pipeline Hugh saw MON’s underappreciated genetic trait pipeline:

26. Why are genetic seeds valuable? Global arable land per capita is doing down Can’t slow population growth or increase land “growth” Need to increase productivity per acre

27. How do you increase productivity? Use more fertilizer? –Up to a certain point, using more fertilizer doesn’t lead to more corn Use more water? –There are lots of competing needs for water.

28. Genetic traits embedded inside seeds to increase productivity: Roundup Ready YieldGard Rootworm Drought Tolerant High Lysine Corn Borer MON’s Solution

29. Continue to invest in R&D to stay ahead of competition & continually sell the best seed Clear value proposition for the farmer: their income goes up Increase penetration through new traits Pricing power: new traits have higher prices MON’s Growth Strategy

30. Barriers to Entry: R&D investments >> very expensive & time consuming to replicate Substitutes: Competitive genetic seeds have much lower yields. Buyer Power: Farmers are relatively fragmented & MON sets pricing Rivalry: Syngenta, Dow, DuPont Supplier Power: Not Relevant Porter’s Five Forces

31. Fundamental Analysis Excellent Revenue Growth

32. Fundamental Analysis Excellent Operating Profit & Margin Growth

33. Fundamental Analysis Excellent EPS Growth

34. Fundamental Analysis Return on Equity Continues to Improve

35. Fundamental Analysis FCF generation remains very strong

36. MON current stock price = $93 Stock is up 77% year to date (YTD) Recently hit all time high at $99.98 on 11/8/07 MON is trading at 35x Street Analyst 2008 EPS estimates of $2.60, and 30x 2009 EPS estimates of $3.10. P/E multiple is at an all time high Technical Analysis (Valuation)

38. Investment Opportunities Clear revenue growth drivers going forward: –Pricing, Volume (share gains), Mix (selling higher priced seeds) –New Products: drought tolerant, nitrogen corn will support future revenue growth No significant major cost investments –Ongoing R&D, but not a lot of capital expenditures Revenues should grow faster than costs >> both profits & EPS will continue to grow Both FCF generation & ROE should continue to improve given few incremental costs & investments needed to grow Fantastic mgmt team with shareholder oriented focus (dividends, share repurchases)

39. Investment Risks Consumer backlash to genetically modified foods Regulatory changes that prevent penetration Competitors catch up over time Pressure on farmer income Risk to P/E, this is a growth stock

40. Investment Recommendation We believe that MON will continue to hold a monopoly on the genetic seed market. MON will continue to grow earnings through both share gains, price increases and cost leverage. While valuation is pricey at 30x CY09 EPS, MON should continue to grow EPS >25-30% for the next few years We think the P/E will approach 35x for CY09 EPS implying a target price of $110, or 20% upside over the next year

41. Review An investment conclusion is based on many factors coming all together –Your assumptions, analysis, and beliefs Backed by sound technical and financial analysis Should be able to sum up your recommendation in an “elevator pitch”

42. Looking ahead Next two weeks: guest speakers Market factors and trends: Economic outlook –Speaker NAME –Knowing when to invest and perhaps seeing which industries should be emphasized, and which should be avoided Other investments –Speaker NAME –What other investments should be made? A quick overview of other investments

43. Q&A